Evaluation of C-2-substituted 19-nor-1alpha,25-dihydroxyvitamin D3 analogs as therapeutic agents for prostate cancer (Q40185846)

From Wikidata
Jump to navigation Jump to search
scientific article published on 4 January 2007
edit
Language Label Description Also known as
English
Evaluation of C-2-substituted 19-nor-1alpha,25-dihydroxyvitamin D3 analogs as therapeutic agents for prostate cancer
scientific article published on 4 January 2007

    Statements

    Evaluation of C-2-substituted 19-nor-1alpha,25-dihydroxyvitamin D3 analogs as therapeutic agents for prostate cancer (English)
    4 January 2007
    3-5
    717-720

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit